Efficacy and Safety of Atorvastatin for Chronic Subdural Hematoma: An Updated Systematic Review and Meta-Analysis
G de Almeida Monteiro, TS de Queiroz… - World Neurosurgery, 2024 - Elsevier
Background Chronic subdural hematoma (CSDH) is a common neurological condition,
especially in the elderly population. Atorvastatin has shown the potential to reduce the …
especially in the elderly population. Atorvastatin has shown the potential to reduce the …
经钻孔引流术治疗慢性硬膜下血肿患者血清TSP1, TSP2, bFGF, VEGF, S-100β 水平变化及其临床意义
吴颐， 叶明， 高觉民， 李建 - 分子影像学杂志, 2024 - j-fzyx.com
目的探讨经钻孔引流术治疗慢性硬膜下血肿患者血清血小板反应蛋白1 (TSP1),
血小板反应蛋白2 (TSP2), 碱性成纤维细胞生长因子(bFGF), 血管内皮生长因子(VEGF) …
血小板反应蛋白2 (TSP2), 碱性成纤维细胞生长因子(bFGF), 血管内皮生长因子(VEGF) …
Changes and clinical significance of levels of serum TSP1, TSP2, bFGF, VEGF and S-100β in patients with chronic subdural hematoma treated by drilling and …
WU Yi, YE Ming, GAO Juemin, LI Jian - 分子影像学杂志, 2024 - j-fzyx.com
Objective To explore the changes and clinical significance of levels of serum platelet-
reactive protein 1 (TSP1), platelet-reactive protein 2 (TSP2), basic fibroblast growth factor …
reactive protein 1 (TSP1), platelet-reactive protein 2 (TSP2), basic fibroblast growth factor …